RecallDepth
Class I Terminated

Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).

This recall has been terminated (originally issued November 16, 2022).

Company
Viatris Inc
Recall Initiated
October 7, 2022
Posted
November 16, 2022
Recall Number
D-0058-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
22400 syringes
Firm Location
Canonsburg, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: AJ21002, Exp. 03/2024

More recalls by Viatris Inc

View all recalls by this company →

Other recent Class I Drug recalls